| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Unknown |
| Molecule Category: | UNKNOWN |
| UNII: | DD50D2QKH1 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Platelet-derived growth factor subunit B inhibitor | Other |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Macular Degeneration | 3 | D008268 | ClinicalTrials |
| von Hippel-Lindau Disease | 1 | D006623 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL3301576 |
| FDA SRS | DD50D2QKH1 |
CONTENTS